Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,330 | 97 | 99.6% |
| Education | $8.45 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $628.56 | 14 | $0 (2024) |
| Amgen Inc. | $246.08 | 15 | $0 (2024) |
| Lilly USA, LLC | $243.92 | 8 | $0 (2024) |
| ABBVIE INC. | $222.73 | 15 | $0 (2024) |
| GENZYME CORPORATION | $175.75 | 6 | $0 (2024) |
| PFIZER INC. | $154.97 | 7 | $0 (2024) |
| Dermavant Sciences, Inc. | $83.46 | 4 | $0 (2024) |
| LEO Pharma Inc. | $72.16 | 3 | $0 (2024) |
| Incyte Corporation | $71.49 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $71.09 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,313 | 61 | Galderma Laboratories, L.P. ($353.02) |
| 2023 | $331.44 | 15 | PFIZER INC. ($94.31) |
| 2022 | $428.47 | 17 | Lilly USA, LLC ($175.01) |
| 2021 | $240.57 | 4 | Galderma Laboratories, L.P. ($215.65) |
| 2020 | $24.86 | 1 | AbbVie Inc. ($24.86) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 11/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.36 | General |
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.94 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.33 | General |
| 09/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: DERMATOLOGY | ||||||
| 09/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 385 | 548 | $99,278 | $34,007 |
| 2022 | 5 | 114 | 120 | $31,524 | $11,559 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $27,524 | $9,468 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 80 | $19,920 | $7,252 | 36.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 54 | 73 | $16,123 | $5,551 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $9,150 | $3,130 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 48 | $8,433 | $2,996 | 35.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 33 | $6,534 | $1,860 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 32 | 44 | $5,761 | $1,614 | 28.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $2,940 | $1,049 | 35.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 25 | 117 | $1,521 | $597.23 | 39.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 11 | 14 | $1,372 | $487.53 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $14,344 | $5,298 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $5,271 | $2,066 | 39.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $5,450 | $1,911 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 19 | $4,237 | $1,532 | 36.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 11 | 11 | $2,222 | $752.55 | 33.9% |
About Dr. Sunaina Likhari, M.D
Dr. Sunaina Likhari, M.D is a Dermatology healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1033430087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunaina Likhari, M.D has received a total of $2,338 in payments from pharmaceutical and medical device companies, with $1,313 received in 2024. These payments were reported across 98 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,330).
As a Medicare-enrolled provider, Likhari has provided services to 499 Medicare beneficiaries, totaling 668 services with total Medicare billing of $45,566. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Sugar Land, TX
- Active Since 06/14/2010
- Last Updated 03/22/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1033430087
Products in Payments
- Otezla (Drug) $246.08
- DUPIXENT (Biological) $221.50
- TALTZ (Drug) $170.58
- SKYRIZI (Biological) $169.84
- AKLIEF (Drug) $144.86
- EUCRISA (Drug) $131.91
- VTAMA (Drug) $83.46
- ADBRY (Biological) $72.16
- OPZELURA (Drug) $71.49
- Sotyktu (Drug) $56.12
- Kerendia (Drug) $37.04
- OLUMIANT (Drug) $32.99
- RINVOQ (Biological) $32.68
- Rybelsus (Drug) $24.00
- CIBINQO (Drug) $23.06
- Tolak (Drug) $22.00
- FARXIGA (Drug) $21.27
- EBGLYSS (Drug) $20.59
- MOUNJARO (Drug) $19.76
- EPSOLAY (Drug) $18.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Sugar Land
Dr. Vandana Madkan, Md, MD
Dermatology — Payments: $650,655
Dr. Jennifer Maender, M.d, M.D
Dermatology — Payments: $34,386
Dr. Lauren Snitzer, M.d, M.D
Dermatology — Payments: $20,826
Dr. Julie Brantley, Md, MD
Dermatology — Payments: $18,301
Mr. Scott Mcmenemy, M.d, M.D
Dermatology — Payments: $12,390
Payal Dixit, D.o, D.O
Dermatology — Payments: $10,756